Subscribe
Pet Food & CPG
7 min read

Geoffroy Lefebvre | CEO, Nasta

After a decade in Swiss luxury watchmaking, Nasta CEO Geoffroy Lefebvre made an unexpected leap into pet food — and found the industries aren't as different as they seem. In this Q&A, he breaks down how craftsmanship and trust translate into pet nutrition, why the category is premiumizing fast, and how Nasta's acquisition of FirstMate unlocks vertically integrated manufacturing in North America.

Written by
Roy Ben-Tzvi
Published on
October 27, 2026
Geoffroy Lefebvre, CEO of Nasta

After a decade in Swiss luxury watchmaking, Nasta CEO Geoffroy Lefevbre made an unexpected move into pet food — and quickly realized the two industries aren’t as different as they seem. In our conversation, he shares how luxury principles like craftsmanship and trust translate into pet nutrition, why the category is rapidly premiumizing, and how Nasta is building a vertically integrated pet food platform across Europe and North America.

‍

‍

You spent years in Swiss watchmaking before stepping into pet care. When you first made that switch, what felt completely different, and what felt surprisingly familiar?

Watchmaking is reputedly a complex endeavour, with hundreds of miniature pieces to compose a mechanical movement. In pet food, the complexity is there as well, but different, for instance, in the variety of regulations you are exposed to as an international business, or simply the fact that it is not an exact science, and a recipe will, in the end, only be validated through palatability testing by actual pets!

Familiar, on the other hand, is the aspiration of customers for always better, more suited, and more sophisticated products, in an industry that is premiumising at a great pace.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Pro
Keep Reading

Other Interviews

More conversations with founders, operators, and investors building the future of pet care.

Learn more
Deven Vespi | Advisor, DRV Advisory
Pet Health & Wellness
13 min read

Deven Vespi | Advisor, DRV Advisory

Clinically proven has no shared definition in pet, yet it now shapes deals as much as labels. Deven Vespi learned the trade in FDA-regulated animal health, and she explains how to check a study before you trust it or build a deal on it. She covers sample sizes, dosing gaps, why brands get blindsided by their own research, and how long published data stays an edge.

Learn more
Learn more
Meet the Founders: 3 Startups Shaping the Future of Pet Health
Pet Health & Wellness
10 min read

Meet the Founders: 3 Startups Shaping the Future of Pet Health

Pawsible Ventures took seven of more than 130 applicants into its second cohort. Three of them work very different corners of pet health. Nicole Shlomof and Gila Leibovitch of Pawp Water sell functional water to owners who already fill the bowl, Andria Beal of EpiPaws turned dolphin epigenetics research into biological-age tests for dogs and cats, and Elliot Greenwood of ChckVet sells software to vet practices that resist new tech.

Learn more
Learn more
Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics
Pet Health & Wellness
17 min read

Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics

Elizabeth Iorns lost her French Bulldog to a brain tumor that a published canine study suggested could be treated, but no company had taken the drug forward for dogs. Now she and Science Exchange co-founder Dan Knox license the companion animal rights to human drugs at Familiar Therapeutics: 13 programs and $5 million raised in five months, plus a pitch to pharma that pet trials validate targets faster than phase two.

Learn more
View all interviews